Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 473

    1.

    Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.

    Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, Randeva HS.

    Diabetes. 2008 Apr;57(4):801-8. Epub 2008 Jan 3.PMID: 18174521 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.

    Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS.

    Diabetes. 2008 Jun;57(6):1501-7. Epub 2008 Mar 28.PMID: 18375437 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.

    Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2764-72. Epub 2007 Apr 24.PMID: 17456573 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Insulin and metformin regulate circulating and adipose tissue chemerin.

    Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, Heutling D, Lewandowski KC, O'Hare JP, Lehnert H, Randeva HS.

    Diabetes. 2009 Sep;58(9):1971-7. Epub 2009 Jun 5.PMID: 19502420 [PubMed - indexed for MEDLINE]Related articles

    5.

    Omentin plasma levels and gene expression are decreased in obesity.

    de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC.

    Diabetes. 2007 Jun;56(6):1655-61. Epub 2007 Feb 28.PMID: 17329619 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Expression of omentin in adipose tissues in obese and type 2 diabetic patients]

    Cai RC, Wei L, DI JZ, Yu HY, Bao YQ, Jia WP.

    Zhonghua Yi Xue Za Zhi. 2009 Feb 17;89(6):381-4. Chinese. PMID: 19567114 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.

    Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS.

    J Clin Endocrinol Metab. 2006 Dec;91(12):5022-8. Epub 2006 Sep 26.PMID: 17003086 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome.

    Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS.

    Diabetologia. 2006 Nov;49(11):2723-8. Epub 2006 Sep 26.PMID: 17001470 [PubMed - indexed for MEDLINE]Related articles

    9.

    Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.

    Tan BK, Adya R, Chen J, Farhatullah S, Heutling D, Mitchell D, Lehnert H, Randeva HS.

    Cardiovasc Res. 2009 Aug 1;83(3):566-74. Epub 2009 May 4.PMID: 19414528 [PubMed - indexed for MEDLINE]Related articles

    10.

    Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.

    Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, Tena G, Preciado R, Lobo R.

    Fertil Steril. 2008 Mar;89(3):642-8. Epub 2007 Jun 11.PMID: 17562334 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance]

    Chu YL, Qiu HY, Sun YY, Li M, Li HF.

    Zhonghua Fu Chan Ke Za Zhi. 2006 Jul;41(7):455-8. Chinese. PMID: 17083810 [PubMed - indexed for MEDLINE]Related articles

    12.

    Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.

    Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE.

    Eur J Endocrinol. 2007 Aug;157(2):201-7.PMID: 17656599 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.

    Seow KM, Juan CC, Ho LT, Hsu YP, Lin YH, Huang LW, Hwang JL.

    Hum Reprod. 2007 Apr;22(4):1100-6. Epub 2007 Jan 5.PMID: 17208941 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.

    Echiburú B, Pérez-Bravo F, Maliqueo M, Sánchez F, Crisosto N, Sir-Petermann T.

    Metabolism. 2008 Dec;57(12):1765-71.PMID: 19013303 [PubMed - indexed for MEDLINE]Related articles

    15.

    Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.

    Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW.

    Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1253-61. Epub 2006 Mar 10.PMID: 16531507 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.

    Pérez-Bravo F, Echiburú B, Maliqueo M, Santos JL, Sir-Petermann T.

    Clin Endocrinol (Oxf). 2005 Feb;62(2):126-31.PMID: 15670186 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome]

    Yang XF, Ren FR, Guo SP.

    Zhonghua Fu Chan Ke Za Zhi. 2006 Apr;41(4):261-3. Chinese. PMID: 16759463 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women.

    Veilleux A, Blouin K, Rhéaume C, Daris M, Marette A, Tchernof A.

    Metabolism. 2009 May;58(5):624-31.PMID: 19375584 [PubMed - indexed for MEDLINE]Related articles

    19.

    Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin.

    Tan BK, Adya R, Shan X, Syed F, Lewandowski KC, O'Hare JP, Randeva HS.

    Diabetes Care. 2009 Jan;32(1):129-31. Epub 2008 Oct 13.PMID: 18852336 [PubMed - in process]Related articlesFree article

    20.

    Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.

    Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J, Pfeifer M.

    Eur J Endocrinol. 2008 Jun;158(6):793-801. Epub 2008 Mar 5.PMID: 18322300 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data